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Message from the Director
I am pleased to present the new National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention: Strategic Plan through 
2020  This Plan updates the Center’s current strategic plan 
and serves as a blueprint for achieving our vision of a future 
free of HIV, viral hepatitis, STDs, and TB  It will guide activities 
across the Center in order to produce the greatest health 
benefit for all Americans 
The Plan sets forth goals to reduce incidence, morbidity, 
mortality, and health disparities related to HIV, viral hepatitis, 
STDs, and TB  Key indicators of progress with ambitious targets 
are included to help us track our progress toward these goals  
The indicators are aligned with national plans including the 
National Prevention Strategy, the National HIV/AIDS Strategy, and 
the HHS Action Plan for the Prevention, Care and Treatment 
of Viral Hepatitis 
The Plan reflects NCHHSTP’s guiding principal of high impact prevention—an approach that 
prioritizes cost-effective and scalable programs, policies, and research  It identifies a set of six key 
strategies which will help us reach our goals  These strategies reflect new opportunities for disease 
prevention created by critical shifts in the national, state, and local economic and policy environ-
ments, including a continually evolving healthcare landscape that emphasizes accountability 
at every level, strategic allocation of resources, and the principles of high impact prevention  
The Plan also articulates the key values held by the Center that guide our actions and interactions 
and it highlights the importance of collaborative effort with partners at the federal, state, and 
community levels in achieving our goals 
This Plan was developed through a participatory process involving staff across the Center  We 
greatly appreciated input from NCHHSTP stakeholders  The Plan will be operationalized through 
the individual strategic plans being developed by each of NCHHSTP’s five divisions  This Plan 
is intended to be a living document—one that we will use to guide our activities and hold 
ourselves accountable at every level of the Center 
Thank you for your continued partnership as we all strive to realize a world free of HIV, viral hepatitis, 
STDs, and TB 
Sincerely,
Jonathan Mermin, MD, MPH
Director
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
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1. About NCHHSTP
The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention is an operating unit 
of the Centers for Disease Control and Prevention (CDC), an agency of the United States Depart-
ment of Health and Human Services (DHHS)  The National Center for HIV, STD, and TB Prevention 
was established in 1994 to coordinate CDC’s HIV, sexually transmitted disease (STD) prevention 
and tuberculosis (TB) elimination programs  In 2006, CDC’s Division of Viral Hepatitis was added 
and the Center was renamed the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Preven-
tion (NCHHSTP)  In January 2012, the Division of Adolescent and School Health—whose activities 
focus on preventing HIV, other STDs, and teen pregnancy and promoting lifelong health among 
youth—joined NCHHSTP 
The infections addressed by NCHHSTP result in high personal, societal and economic costs, both 
in the United States and around the world  Nearly 20 million STDs, including HIV, occur in the 
United States each year, most among young persons; consequences include infertility and ectopic 
pregnancy, as well as cancer and increased risk of HIV  More than 1 2 million persons in the United 
States are infected with HIV, with tremendous personal and economic costs; the lifetime treatment 
costs, excluding costs related to lost work and productivity, are an estimated $402,000 per person 
living with HIV  Approximately 4 4 million persons are living with chronic viral hepatitis infection, 
and viral hepatitides are the leading causes of liver cancer and transplants in the United States  
Due to effective, ongoing, dedicated TB control programs, TB disease is relatively rare in the United 
States, with fewer than 10,000 cases annually  However, millions of Americans are infected with the 
bacteria that cause TB, and, without treatment, are at risk for developing active disease 
These infections have important interactions  Those who are infected with certain STDs, such 
as syphilis or gonorrhea, are at greater risk for acquiring or transmitting HIV  Likewise, those who 
are infected with HIV are more susceptible to TB disease due to weakened immune systems  
And persons coinfected with HIV and either hepatitis B or hepatitis C are at increased risk for liver-
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These infections also share a number of commonalities, including some modes of transmission 
and factors contributing to individual risk  For example, because sexual maturation and develop-
ment occur during adolescence, it is critically important to provide health promotion and disease 
prevention for youth  Many of the infections disproportionately affect people and communities 
facing adverse social and economic conditions, such as elevated rates of poverty, homelessness, 
unemployment, substance use, mental illness, incarceration, homophobia, social stigma, racism, 
limited education, poor housing, poor healthcare access, and other social and structural factors 
associated with poor health status 
These factors contribute to unequal access to and participation in effective, science-based 
interventions including health education, vaccination, screening and treatment  To be effective 
in protecting the health of most affected populations, it is critically important that public health 
programs acknowledge and address these broader realities and contexts 
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2. Vision and Mission
Every year, millions of Americans are infected with HIV, viral hepatitis, STDs or TB, and tens 
of thousands die because of their infection  The financial cost of these infections is staggering  
A conservative estimate for STDs and HIV alone is that the healthcare costs from new infections 
that occur each year cost the United States more than $19 billion 
We as a nation can do better. NCHHSTP is committed to our vision and mission:
Implementing Our Mission: The Importance of Partnerships
Partners are critical to achieving NCHHSTP’s goals  Partners include, but are not limited to, other 
federal agencies, state and local health departments and education agencies, national professional 
associations, businesses, community-based organizations and grantees, faith-based organizations, 
advisory boards and committees, foundations, universities, media and the entertainment industry  
Engaging with partners and members of the affected communities is particularly important as we 
adapt our strategies to meet the needs of a changing environment  Developing relationships with 
world-class leaders in science, medicine, technology, education, community engagement, policy, 
and programmatic management and implementation allows us to provide better leadership to 
our grantees and the public to advance our core mission and reduce HIV, viral hepatitis, STDs and TB 
NCHHSTP vision: 
A future free of HIV, viral hepatitis, STDs, and tuberculosis
NCHHSTP mission: 
Save lives, protect people, and reduce health disparities 
associated with HIV, viral hepatitis, STDs, and tuberculosis
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2.1 Core Values
NCHHSTP is built on core values that guide how we think and work together, how we serve our 
communities, how we make decisions, and how we determine our priorities  They reinforce 
our respect for the people we serve, our colleagues, and ourselves  The following core values drive 
NCHHSTP as a public health organization 
•	  Accountability:  Be a diligent steward of the use of funds to achieve NCHHSTP’s public 
health mission
•	  Respect: Treat persons with dignity and honesty; value diversity and differences of opinion
•	 Integrity: Be accurate, consistent, and honest
•	  Excellence:  Achieve the highest standard of performance in public health science, 
program, and policy
•	 Diversity: Recruit and maintain a highly trained, inclusive, and professional workforce
•	  Transparency:  Keep the public, partners, and staff informed about our programs, 
policy, and science
•	 Equity: Work to achieve optimal health for the populations we serve
•	 Innovation: Create an environment that encourages and values new ideas
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2.2 Guiding Principle: High Impact Prevention
NCHHSTP prioritizes cost-effective and scalable programs, policies, and research that will have 
the greatest impact on its three goals: 1) reducing incidence of infections, 2) lowering morbidity 
and mortality, and 3) decreasing health disparities  High impact prevention is an approach 
to planning and implementing activities that promotes efficient and effective use of limited 
resources  It recognizes that implementing a combination of interventions is not enough—not 
all interventions are effective, and not all effective interventions are equal  The ultimate purpose 
of high impact prevention is to achieve the greatest impact given available human and financial 
resources, whether at CDC, partner agencies and organizations, or the health care system  
High impact prevention requires thoughtful prioritization 
The Center will implement programs, policies and research that:
1  Are most cost-effective in reducing overall incidence, morbidity, mortality and disparities 
in health
2  Can be feasibly implemented at full scale with currently available resources  Programs 
and policies should be practical to implement at the scale needed to meet the need 
in the target population
3  If prioritized, will have the greatest impact on reducing incidence, morbidity, mortality 
and disparities in health when implemented
4  Include populations that are disproportionately affected to reduce disparities 
by ensuring that those with highest rates of morbidity or who are most vulnerable are 
effectively reached
We will evaluate programs and policies and use information gained from routine assessment, 
operational research, and surveillance data to improve outcomes and highlight areas for 
productive, pragmatic research 
Establish cost and 
cost effectiveness 
per infections averted 
and life-years saved
Determine feasibility 
of full scale 
implementation
Develop epidemic 
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3. NCHHSTP Framework
NCHHSTP has revised and updated its strategic plan, reflecting changes in the Center and the 
environment in which the Center operates  This updated plan explicitly includes health impact 
goals and broad strategies designed to enable goal success  The revision has a clear connection 
to national plans—the National Prevention Strategy, the National HIV/AIDS Strategy, and the HHS 
Action Plan for Viral Hepatitis—released since the 2010 strategic plan was drafted  See Appendix 
A for descriptions of these and other national frameworks  It also sets the stage for division plans, 
which will serve to operationalize this strategy 
A Future Free of HIV, Viral Hepatitis, STDs, and TB
Mission: Save lives, protect people, and reduce health disparities associated 
with HIV, viral hepatitis, STDs and TB
Guiding Principle: High Impact Prevention –  Maximize impact through efficient 
implementation of cost-effective and feasible interventions, policy and research
Decrease Incidence 
of Infection















Increasing Knowledge and 
Adoption of Healthy Behaviors
Prevention through 
Healthcare
 •  Target, prioritize, and improve programs using surveillance data; 
other program data; and modeling, evaluation and research results
 •  Address critical scientific gaps by identifying, developing and 
evaluating interventions, policies and technologies
 •  Increase knowledge and promote adoption of behaviors that 
prevent infection and associated morbidity and mortality
 •  Maximize opportunities afforded by the healthcare system for 
preventing infections, morbidity and mortality
 •  Promote better collaboration across divisions in design and imple-
mentation of surveillance, research, communication, and prevention 
programs to support service integration and utilize Center and 
partner resource most effectively
 •  Support excellence in science and program; ensure efficient business 
and scientific administration; implement effective communication 










4. Goals Through 2020
NCHHSTP has three overarching goals regarding HIV, viral hepatitis, STDs, and TB:
•	 Decrease incidence of infection
•	 Decrease morbidity and mortality
•	 Decrease health disparities
NCHHSTP will track progress toward these goals using a small set of indicators  These indicators 
represent the highest level of impact expected from the program, are measurable on a regular 
basis, and align with goals in other relevant plans and frameworks  The set may be updated 
if annual or biennial data become available to measure other important impacts, such as aware-
ness of hepatitis B status among at risk populations, incidence of latent TB infection, or co-infec-
tions  Indicators related to HIV will be revised as necessary to align with the update of the National 
HIV/AIDS Strategy  They may also be updated if significant changes occur in other national plans 
or if improved methods of measurement become available  Details regarding how the indicators 
were developed and calculated are included in Appendix B  More specific indicators will be moni-
tored through division plans and funded programs 
4.1 Goal 1:  Decrease incidence of infection with HIV, viral hepatitis, 
STDs, and TB
Progress has been made in reducing rates of hepatitis A and B, gonorrhea and TB  There have 
also been promising reductions in HIV among some populations and, most recently, in chlamydia  
However, incidence of other infections, such as hepatitis C and syphilis, has increased as these 
infections have spread to different populations, and rates of all of these preventable infections 
remain unacceptably high 
4.2 Goal 2:  Decrease morbidity and mortality from HIV, viral hepatitis, 
STDs, and TB
Untreated HIV, viral hepatitis, STDs and TB infections can cause serious health problems, including 
death  Yet these health problems can be avoided, and transmission of new infections reduced, 
with screening and treatment with appropriate therapies 
4.3 Goal 3:  Decrease health disparities across groups affected 
by HIV, viral hepatitis, STDs, and TB
Differences in HIV, viral hepatitis, STDs and TB occur by factors such as gender, age, race or ethnic-
ity, education, income, disability, geographic location and sexual orientation  Social determinants 
of health such as poverty, unequal access to health care, limited education, stigma, and discrimi-
nation are linked to these health disparities  In addition to reducing HIV, viral hepatitis, STDs, and 
TB overall, NCHHSTP aims to reduce the preventable disparities in health associated with these 
infections 
NCHHSTP will track progress toward these goals using the following indicators 
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Goal 1: Decrease Incidence of Infection
1 1 Reduce new diagnoses of HIV, acute hepatitis B, acute hepatitis C, and TB
1 2 Reduce the rate of increase of primary and secondary syphilis
1 3  Increase the percentage of high school students who have not had sex or who 
use condoms if sexually active
Goal 2: Decrease Morbidity and Mortality
2 1 Reduce deaths from hepatitis B and hepatitis C
2 2 Increase the proportion of persons with HIV who achieve viral suppression
2 3  Increase the proportion of persons with gonorrhea who are treated with an effective 
antibiotic regimen
2 4  Increase the proportion of persons with HIV, hepatitis B or hepatitis C who are aware 
of their infection
2 5 Increase HIV testing among school aged youth
2 6 Increase HIV testing among STD clinic patients who are diagnosed with an acute STD
2 7 Increase the proportion of young females who are screened for chlamydia
Goal 3: Decrease Health Disparities
3 1  Reduce diagnoses of HIV and TB among racial/ethnic minority populations with rates 
above the national average
3 2  Reduce new HIV diagnoses among men who have sex with men MSM and people 
who inject drugs
3 3 Reduce the rate of TB among foreign born persons
3 4   Increase the proportion of MSM, African Americans, and Hispanics who have achieved 
HIV viral suppression
3 5  Reduce the proportion of young sexual minority males in schools who have 
engaged in HIV/STD risk behaviors
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NCHHSTP Work with State and Local Governments
NCHHSTP works closely with state and local health departments and education agencies 
to reduce incidence, morbidity, mortality, and health disparities due to HIV, viral hepatitis, STDs 
and TB  NCHHSTP provides technical support and funding to these agencies to achieve our shared 
goals  NCHHSTP works with:
•	  Health departments to conduct HIV surveillance, prevention program implementation, 
routine program monitoring and evaluation, and capacity building
•	  State and local education agencies to work with schools to reach at-risk youth and deliver 
risk reduction programming; and state and local health and education agencies to conduct 
school-based surveillance of health risk behaviors and school health policies and practices
•	  Health departments to conduct STD assessment, including disease surveillance, 
assurance activities, and policy development
•	  Health departments to deliver tuberculosis prevention and control activities, including 
surveillance, contact investigations, targeted testing of high risk populations, case manage-
ment, laboratory testing, human resource development, and directly observed therapy
•	  State coordinators to integrate viral hepatitis prevention activities into existing public health 
programs and improve viral hepatitis screening and linkage to care
In addition, NCHHSTP assigns field staff to state and local agencies to build the agencies’ 
capacity to prevent and control HIV, STD and TB  These field staff not only provide critical 
support to infectious disease control programs, but are also called in as standing capacity 
to provide critical public health services, such as contact tracing and field investigation, 
in the event of public health emergencies 
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5. Key Strategies
Strategy
Using Data for Program 
Improvement
Target, prioritize, and improve programs using surveillance 
data; other program data; and modeling, evaluation and 
research results 
Scientific Discovery and 
Evaluation
Address critical scientific gaps by identifying, developing 
and evaluating interventions, policies and technologies 
Increasing Knowledge 
and Adoption of Healthy 
Behaviors
Increase awareness and promote adoption of behaviors 
that prevent infection and associated morbidity and mortality 
Prevention through 
Healthcare
Maximize opportunities afforded by the healthcare system 
for preventing infections, morbidity and mortality 
Program Collaboration and 
Service Integration
Promote better collaboration across divisions in design and 
implementation of surveillance, research, communication, 
and prevention programs to support service integration and 
utilize Center and partner resources most effectively 
Organizational Excellence Support excellence in science and program; ensure efficient 
business and scientific administration; implement effective 
communication and policies; enhance skills of current staff; 
and develop the NCHHSTP public health workforce  
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5.1  Using Data for Program Improvement: Target, prioritize, and 
improve programs using surveillance data; other program data; 
and modeling, evaluation and research results
Highly effective interventions—testing, treatment, partner services and contact tracing, vaccination, 
education, and health-supporting policies—can reduce the burden of HIV, viral hepatitis, STDs, 
and TB  Nevertheless, these infections occur frequently and are often concentrated in certain 
populations, and in specific regions of the country  Better targeting and implementation 
of combinations of scientifically proven, cost-effective, and scalable interventions is needed 
to achieve NCHHSTP health goals 
Data on disease burden; risk factor prevalence; availability, use, quality, and outcomes of services; 
and intervention effectiveness and cost-effectiveness can help NCHHSTP and its prevention 
partners improve targeting and implementation of prevention programs  For example,
•	  Data regarding the geographic distribution of disease and at-risk populations reveal 
profound disparities in health and are being used to guide the allocation of NCHHSTP’s 
extramural funding to state and local health departments, community-based organizations, 
and education agencies
•	  Data on the HIV continuum of care reveal important areas needing intervention, such as HIV 
testing and retention in care and populations most in need of those interventions
•	  Analyses of hepatitis C data revealed that only 50 percent of persons with hepatitis C are 
aware of their infection and that 30 percent of persons with hepatitis C will die of hepatitis C 
related complications that could be avoided with care and treatment
•	  STD surveillance data indicate that a significant portion of chlamydia diagnoses among 
women are made by private physicians or HMOs, highlighting the importance of working 
with the larger healthcare system
•	  Reports from the National TB Indicators Project (NTIP) reveal important achievements in TB 
prevention, as well as populations where focused efforts are still needed  For example, 
in 2011, 97 percent of patients completed treatment and 89 percent of TB patients completed 
a course of treatment within 12 months 
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5.1.1 What NCHHSTP will do
NCHHSTP will incorporate disease data to allocate funding within programs to populations and 
areas in greatest need of interventions  For example, NCHHSTP will
•	  Refine formula funding for its major health department prevention programs as new project 
cycles begin
•	  Work with grantees to align their resources and efforts with the burden of disease in their 
jurisdictions and will monitor grantee progress in doing so
NCHHSTP will modernize disease surveillance and increase use of new sources of data  
For example, NCHHSTP will
Participate in CDC’s efforts to modernize notifiable disease reporting using informatics industry 
standards through the National Notifiable Disease Surveillance System (NNDSS) Modernization 
Initiative  The modern NNDSS aims to improve the ability of state and local health department 
personnel to collect, validate, analyze, transmit and share standardized health-related data
•	  Refine and improve the collection of data regarding MSM, transgender persons, heterosexuals, 
and persons who inject drugs through surveys such as the Youth Risk Behavior Surveillance 
System and the National HIV Behavioral Surveillance system, as well as special analyses 
and studies
 Increase the use of other data sources, including commercial lab reports and Centers for Medicare 
and Medicaid Services (CMS) Medicaid and commercial claims data, to provide a more complete 
and timely picture of risk factors, infections, disease state, outcomes, and access to services 
nationally and across jurisdictions
•	  Work with its grantees to build partnerships with private and public healthcare provider 
groups, agencies and consortia developing regional health information exchanges, and 
safety net providers to obtain, utilize, and share relevant data with state and local health 
departments
•	 Work to improve the timeliness of surveillance data release
NCHHSTP will assess and improve the provision and impact of prevention, care and treatment  
For example, NCHHSTP will
•	  Improve monitoring of the continuum of care for HIV and hepatitis B and the continuum 
of care to cure for hepatitis C for the nation
•	  Provide guidance and assistance to local jurisdictions to develop and use their own 
continuums for HIV, and where available, hepatitis B and hepatitis C, to assess provision 
of prevention, care and treatment services in their areas and, through local providers and 
case managers, test, link to care, and re-engage individuals who have fallen out of care
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•	  Provide assistance to education agency grantees to improve the assessment of sexual health 
services available to teens and work with the education system to improve access and use 
of these services
•	  Provide assistance to STD and TB programs to better utilize available data to assess and 
assure the provision and quality of screening and treatment services in their jurisdictions
NCHHSTP will incorporate new knowledge into program and practice guidance  
For example, NCHHSTP will
•	  Develop, evaluate and provide guidance to the public health community regarding highly 
effective interventions, and encourage grantees to those found to be most cost-effective
•	  Conduct prevention effectiveness modeling to assess policy and resource allocation options, 
and estimate the impact and cost-effectiveness of public health interventions 
•	  Conduct surveillance and research specifically with MSM across the lifespan, people 
who inject drugs, youth, and young adults to assure guidelines address their specific 
risks and needs
•	  Provide assistance and advice to multilateral organizations to help them incorporate new 
knowledge into international guidelines and recommendations
•	  Provide information to other health and social service agencies regarding the health impacts 
of social and structural factors such as housing and employment and provide advice and 
guidance to state and local health programs to foster local linkages to these services 
to address upstream risks
NCHHSTP will monitor prevention program progress and provide timely feedback  
NCHHSTP will
•	 Produce national reports to inform our stakeholders of progress towards national goals
•	  Use surveillance and program data to produce reports to provide state level information 
on prevention progress
•	  Use performance data to provide program feedback reports to grantees to help them gauge 
how they are doing relative to others
•	  Support routine and systematic, integrated use of surveillance and program data for 
decision making and program improvement efforts at every level in the Center
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5.1.2 Expected results
As a result of full implementation of this strategy, NCHHSTP and its health department and 
education agency partners will provide more timely, accurate, and complete data on risk behaviors, 
HIV, viral hepatitis, STDs and TB to policy makers, prevention program managers and the public  
Surveillance will be improved to fill critical data gaps data, such as those that exist for viral 
hepatitis  Grantees will better monitor provision of screening and treatment at the state and local 
level and use such data to improve program planning and prioritize public health interventions  
NCHHSTP and grantee performance will continually improve due to better prioritization, monitoring 
and program feedback  Ultimately, the burden of HIV, viral hepatitis, STDs and TB, and health 
disparities due to these infections, will be reduced 
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5.2  Scientific Discovery and Evaluation: Address critical scientific gaps 
by identifying, developing and evaluating interventions, policies 
and technologies
Scientific discoveries have been critical to the success in reducing HIV, viral hepatitis, STDs, and 
TB in the United States and around the world  CDC has contributed to many of these discoveries 
including the following:
•	  Discovery of methods to prevent mother to child transmission of HIV, which led to dramatic 
reductions in infant infections, and gave rise to research that showed antiretrovirals to be 
effective in preventing HIV acquisition (post exposure prophylaxis [PEP] and pre-exposure 
prophylaxis [PrEP]) and transmission in other populations
•	  Improvements in treatments, such as a shortened regimen for treatment of latent TB 
infection, which can improve completion rates and patient outcomes and further drive 
down morbidity
•	  Development and improvement of technologies to test for infection, such as new HIV and 
hepatitis C diagnostic algorithms that can identify and differentiate between acute and 
established infections; blood tests for TB, which, unlike the tuberculin skin test, do not 
require a follow up visit if the person is uninfected; molecular drug resistance testing 
to rapidly and effectively identify persons in need of second line drugs for TB; and genomic 
sequencing that can be used to identify, or rule out, related transmissions
•	  Development and refinement of effective public health interventions, such as directly 
observed therapy for TB, which turned the tide on the TB resurgence in the 1990s and 
remains a critical strategy today; expedited partner therapy for chlamydia to treat partners 
of persons with infection; and targeted vaccination strategies, such as that used to eliminate 
racial/ethnic disparities in hepatitis A infection
Yet, despite this progress, critical gaps in prevention knowledge remain  For example, better 
tolerated and shorter treatments are urgently needed for TB, particularly drug-resistant TB  
Improved strategies are needed to address continued high rates of HIV and STDs among MSM, 
to eliminate mother to child transmission of hepatitis B virus and to stop the emerging epidemic 
of hepatitis C infections among young people who inject drugs  New scientific discoveries, 
as well as evaluations to demonstrate how best to practically apply existing knowledge, can help 
improve population health and reduce disparities 
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5.2.1 What NCHHSTP will do
NCHHSTP will develop better methods for identifying and analyzing gaps in its research portfolio 
and identify strategies to help fill those gaps  NCHHSTP will also continually refine and improve the 
quality of its scientific products  Critical areas of inquiry identified thus far include the following 
•	  Monitoring changes in the population, the environment and the infectious agents that may 
require new prevention and control strategies  For example, NCHHSTP is monitoring new 
cases of hepatitis B to detect changes in the viral strains that may require modification 
to available vaccines  NCHHSTP is also monitoring bacterial and viral isolates from patients 
for drug-resistant strains of TB, gonorrhea and HIV so that recommended treatments can 
be adjusted if needed  NCHHSTP is monitoring changes in risk behaviors, such as increased 
injecting drug use by rural youth, which has been associated with recent increases in acute 
HCV infections, and STD biomarkers as risk factors for HIV infection
•	  Evaluating the utility of advanced molecular diagnostics and whole genome sequencing 
to identify clusters of related infection and characterize transmission networks and allow 
for public health intervention  This work will focus the public health response, obviating 
the need for extensive investigation of unrelated cases of transmission  It may also lead 
to the development of point of care diagnostics that can identify drug-resistant strains 
and inform treatment
•	  Providing technical assistance and scientific expertise to multilateral organizations and 
other countries to investigate scientific questions important to the development and 
implementation of effective control programs
•	  Collaborating with NIH and other organizations to develop, predict and validate the 
impact of biomedical and behavioral tools for disease prevention, including research 
on pre-exposure prophylaxis PrEP for HIV; PEP and treatment adherence; better tests 
and testing algorithms; and care and treatments, including shorter TB treatment regimens, 
and treatment for antimicrobial resistant infections
•	  Developing and assessing implementation strategies for new prevention tools, such 
as a shorter 3 month regimen for treating latent TB infection, HIV PrEP, and treatments 
for Hepatitis C
•	  Collaborating with other public health agencies to develop prevention strategies and 
program plans for emerging public health problems including antimicrobial resistant 
bacteria and increasing rates of opioid drug abuse
•	  Ensuring the availability and use of sound scientific evidence to underpin feasible and 
cost-effective policies, guidelines, and recommendations for laboratory testing and 
diagnosis, interventions and treatment
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•	  Assessing the implementation, effectiveness and impact of program interventions and 
policies to prevent and control infections, such as implementation of school health 
education to prevent HIV and STDs; vaccines for human papillomavirus (HPV), and hepatitis 
B; voluntary, opt-out HIV testing in clinical settings; recommended testing for chlamydia, 
gonorrhea, syphilis, HIV, hepatitis B, and hepatitis C; self-administered therapy using shorter 
regimens to treat latent TB infection; and expedited partner services to treat partners 
exposed to chlamydia
•	  Building the evidence base regarding protective factors for youth, especially LGBT youth, 
to guide school, community, and parent-based interventions to improve outcomes
•	  Utilizing program data to identify emerging issues at the program level that would 
benefit from timely and rigorous, in-depth assessment
5.2.2 Expected results
Taken together, these efforts should provide the tools and knowledge needed to increase the 
effectiveness, efficiency and impact of HIV, viral hepatitis, STDs, and TB prevention programs  More 
specifically, new prevention challenges will be uncovered and addressed  Models for how to better 
combine and implement prevention interventions will be developed, evaluated, and packaged  
Finally, the knowledge necessary to inform CDC and international recommendations for disease 
prevention and control will be advanced 
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5.3  Increasing Knowledge and Adoption of Healthy Behaviors: 
Increase knowledge of HIV, viral hepatitis, STDs and TB, 
and promote adoption of behaviors that prevent infection 
and associated morbidity and mortality
Knowledge about transmission pathways, effects on health and means to prevent HIV, viral  
hepatitis, STD, and TB is foundational to the adoption of healthy behaviors, yet is highly variable 
in the U S  population  Further, knowledge alone is not sufficient  All persons, especially young 
people and members of disproportionately affected groups, need skills to adopt health protecting 
behaviors, including seeking appropriate healthcare  Public health and healthcare professionals 
can encourage and promote healthy behaviors and the receipt of critical health services  
For example,
CDC assistance to state and local education agencies has helped ensure that health and education 
policies and practices support adolescent health, development, and information about how 
to effectively educate young people about HIV and other STDs 
•	  Targeted communication campaigns have educated Americans about the threat of HIV and 
how to prevent it, promoted testing and engagement in care for HIV, hepatitis B, hepatitis C, 
and STDs
•	  CDC informational materials for the public and providers, including fact sheets, webpages, 
and social and digital media, as well as recommendations, are widely accessed and trusted 
sources of health information  For example, TB patient education and adherence enhancing 
activities have been a critical part of overall case management  CDC’s STD Treatment 
Guidelines mobile app combines information from CDC’s STD Treatment Guidelines and 
MMWR updates and has been downloaded more than 830,000 times
•	  Training centers for TB and STD provide health professionals with a spectrum of state- 
of-the-art educational opportunities
5.3.1 What NCHHSTP will do
CDC will conduct communication and educational campaigns; develop, evaluate and share 
educational materials and curricula for target populations; develop and implement educational 
programs, and, with its public health and academic partners, support trainings and provide educa-
tional materials to educators and public health and healthcare providers  Efforts will be evaluated 
and refined to ensure that they are effective in reaching the desired results  NCHHSTP will
•	  Support efforts to educate all youth and disproportionately affected populations regarding 
health protecting behavior  Activities include
o Establishing health messages and dissemination mechanisms for all teens, as well 
as their parents/caregivers and teachers
o Developing, and helping partner organizations develop, clear, understandable and 
actionable education and communication materials and programs
o Supporting health education and risk reduction programs for persons at highest risk 
of infection
22
•	  Use traditional and new media to reach people of all generations with life-saving health 
information, including resources for prevention, testing and linkage to care for those most 
at risk of infection  Key efforts include
o Conducting communications campaigns to promote HIV awareness and the reduction 
of HIV-related stigma among the general public and populations with highest rate 
of infections
o Conducting targeted communication campaigns to promote testing and care among 
populations with the highest rates of infections
o Identifying how best to effectively use new communication technologies to reach 
populations that do not, or have not, accessed traditional communication channels
o Adapting public health messages and communication as needed to take into account 
new prevention tools and strategies, including PrEP
•	  Create resources and educational opportunities so that public health and healthcare 
providers have the latest information available regarding guidelines/recommendations and 
best practices  For example, NCHHSTP will
o Develop user-friendly tools, based on models of impact and cost effectiveness 
of prevention strategies, that practitioners and policy-makers at the national, state and 
local levels can use to improve program effectiveness
o Raise awareness among state and local health officials regarding matters of impor-
tance in HIV, viral hepatitis, STD and TB prevention, including how to recognize and 
address outbreaks
o Promote the adoption of improved tests and testing strategies, such as nucleic acid 
amplification tests (NAAT) to provide more rapid diagnosis of TB and guidelines for HIV 
and HCV laboratory testing
o Promote utilization of new technologies by providers to improve adherence to CDC 
screening and treatment recommendations, such as clinical decision support systems 
in electronic medical records
o Provide outreach, training, continuing medical education opportunities, and expert 
consultation to primary care providers to better serve patients with and at risk for 
HIV, viral hepatitis, STDs, or TB, assisting with referral to specialized care as needed  
NCHHSTP will also continue to conduct outreach to primary care to promote testing 
for HIV, viral hepatitis, and STDs and other recommended prevention services, such 
as expedited partner therapy for chlamydia and gonorrhea
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5.3.2 Expected results
Implementation of this strategy will improve the health, including the sexual health, of the 
U S  population  Adolescents will have the fundamental health knowledge and skills to establish 
healthy behaviors for a lifetime, connect to health services, and avoid HIV, viral hepatitis, STDs, TB, 
and unintended pregnancy  Adults will have the knowledge and skills needed to reduce their risk 
of infection, and to seek appropriate care to preserve their health and that of their families and 
partners  Public health and health care professionals will be equipped with the latest information 
and necessary skills to conduct effective control programs and provide prevention and care 
services most effectively 
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5.4  Prevention through Healthcare: Maximize opportunities afforded 
by the healthcare system for preventing infections, morbidity, and 
mortality
Services delivered in the healthcare or clinic setting, such as vaccination, screening, treatment and 
behavioral counseling are critical to the prevention and control of HIV, viral hepatitis, STDs and TB  
These systems of care are changing, partly as a result of the Affordable Care Act and partly reflect-
ing other drivers of change, such as technological and scientific advances  These changes include 
the following:
Increased number of persons with health insurance, who may now be more likely to seek and 
receive preventive and treatment services 
•	 Increased emphasis on quality in healthcare, with a focus on prevention and well-being
•	  Different payment structures developed in response to concerns about increasing costs, 
that emphasize improvement in outcomes and value, and that rely less on fee-for-service 
reimbursement
•	  Increased emphasis on systems of care that place primary care at the center of a network 
of providers who share the necessary tools and incentives to provide coordinated services
•	  Marked expansion of electronic medical records, with increased availability of data across 
information systems, providing new opportunities to track quality metrics
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Such system changes are supported by and are transforming the roles of major healthcare 
providers and payers  For example, the number of persons served by community health centers 
is expanding dramatically  Many states are expanding their Medicaid programs to cover 
an increasing portion of the uninsured population  However, the uneven expansion of Medicaid 
across the country is likely to exacerbate disparities in health nationwide, posing additional 
challenges to prevention programs, particularly those in non-expansion states  Increasingly, state 
Medicaid programs are driving quality improvement and the Center for Medicare and Medicaid 
Innovation (CMMI) is investing in alternative approaches to service delivery that improve health 
outcomes 
Finally, some specific Affordable Care Act (ACA) provisions provide new opportunities for prevention 
of HIV, viral hepatitis, STDs, and TB  For example, many preventive services (those with an A or B 
recommendation by the U S  Preventive Services Task Force [USPSTF], those recommended by the 
Advisory Committee for Immunization Practices (ACIP), or by HRSA for children and women) are 
now covered by most insurance plans without cost-sharing  These include services such as vac-
cination for hepatitis A, hepatitis B, and HPV; screening for chlamydia, gonorrhea, HIV, hepatitis B 
and hepatitis C; and high intensity behavioral counseling for those at high risk for STDs 
Fostering public health and primary care collaboration
NCHHSTP worked with ASTHO, NACCHO, the National Coalition of STD Directors (NCSD) and 
the National Association of Community Health Centers (NACHC) to promote collaboration 
between health departments and FQHCs  Links to webinars and a report from this project 
“A Practical Look at Using Integration to Better Prevent and Treat Sexually Transmitted 
Diseases” are available at: http://www astho org/Programs/Infectious-Disease/Hepatitis-HIV-
STD-TB/Sexually-Transmitted-Diseases/Integration-Webinar-Series/
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5.4.1 What NCHHSTP will do
NCHHSTP will adopt the following approaches to take advantage of the opportunities offered 
by the changing healthcare landscape:
Utilize economic and health services data to create business cases for public and private payers 
and employers to include the provision of innovative, effective preventive services, such 
as expedited partner therapy and partner notification, in health plan coverage
•	  Collaborate with stakeholders, including state Medicaid offices, major nongovernmental 
organizations, other federal agencies and other parts of CDC to encourage inclusion 
of HIV, viral hepatitis, STD, and TB outcomes in strategies and initiatives sponsored 
by those organizations
•	  Prepare NCHHSTP-funded health departments and community-based organizations to work 
more closely with healthcare delivery systems such as federally qualified health centers 
(FQHCs), patient centered medical homes and accountable care organizations to improve 
testing, and linkage to care and treatment 
•	  Prepare NCHHSTP-funded education agencies to work more closely with health departments 
and healthcare delivery systems to establish school-based health centers or linkage and 
referral systems to connect teens to recommended clinical preventive sexual health services
•	  Leverage opportunities created by the ACA and other federal policies regarding reimburse-
ment for recommended clinical preventive services, to encourage provision of services vital 
to the control of HIV, viral hepatitis, STDs, and TB  Examples include
a   Collaborating with CMS, state Medicaid programs and other payers on performance 
incentives for healthcare providers
b   Increasing awareness among at-risk populations regarding insurance 
coverage without cost sharing of relevant preventive services
c   Conducting analyses and providing evidence to the ACIP and USPSTF to support 
and improve clinical recommendations addressing HIV, viral hepatitis, STDs, and TB
•	  Foster improvements in the provision of healthcare for HIV, viral hepatitis, STDs, and TB 
by leveraging new performance measurement initiatives and changes in information 
technology  NCHHSTP would collaborate with HRSA and CMS for activities such as
o Development of clinical decision support tools that can be incorporated into electronic 
health record systems
o Development, standardization and promulgation of core performance/clinical quality 
measures, such as those for hepatitis C, STDs, TB and HIV screening and treatment
o Development of checklists, applications, feedback reports and other tools to increase 
the delivery of recommended services in health care settings
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5.4.2 Expected results
Taken together, these actions aim to influence the healthcare system to address the needs 
of patients in a more holistic manner and increase the quality and delivery of recommended 
preventive services for HIV, viral hepatitis, STDs, and TB in healthcare settings, particularly among 
disadvantaged populations 
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5.5  Program Collaboration and Service Integration: Promote better 
collaboration across divisions in design and implementation 
of surveillance, research, communication, and prevention 
programs to support service integration and to utilize Center and 
partner resources most effectively
Program collaboration and service integration (PCSI) is a mechanism of organizing and blending 
interrelated health issues, separate activities, and services in order to maximize public health 
impact through new and established linkages across programs to facilitate the delivery of services  
Through PCSI, NCHHSTP strengthens collaborative work across disease-specific programs, develops 
capacities that can be shared across programs, and integrates services at the individual, or client, 
level 
NCHHSTP has issued population specific recommendations that address populations in a more 
holistic manner; developed joint guidelines and trainings to enable grantees and staff to better 
address related infections; developed internal mechanisms to facilitate cross-Center project officer 
collaboration; and allowed its health department grantees to allocate a portion of their awards 
to PCSI efforts  For example, NCHHSTP
•	  Awarded funding to six health departments for integration of health services  New York City, 
North Carolina, Philadelphia, San Francisco, Texas, and Washington, D C , were funded 
as PCSI demonstration sites to plan, scale-up, and support the implementation of a syndemic 
approach for the prevention of HIV/AIDS, viral hepatitis, STDs and TB  Success stories were 
disseminated through NCHHSTP’s website to showcase accomplishments and lessons 
learned
•	  Issued comprehensive partner services recommendations that cover both STD and HIV 
infections  Previously, there were separate STD and HIV partner services recommendations
•	  Issued data security and confidentiality standards for HIV, viral hepatitis, STD, and TB surveil-
lance  Adoption of these standards is the necessary first step in securely sharing surveillance 
data across programs to improve program effectiveness
•	  Issued integrated preventive services recommendations for persons who inject drugs, 
providing a single reference for prevention and healthcare providers serving this at risk 
population
•	  Developed the ATLAS—a data visualization tool that serves as a single platform to dissemi-
nate comparable state and county level data on HIV, syphilis, gonorrhea, chlamydia, TB, and 
hepatitis A, B and C
•	  Developed an information technology platform to coordinate site visits by NCHHSTP project 
officers and initiated quarterly project officer meetings
•	  Conducted communication research on how people think about STIs to identify opportunities 
for effective prevention messages addressing overlapping epidemics
•	  Developed the Pacific Islands FOA, which combines multiple prevention program activities 
across disease areas into one program plan to better support prevention program capacity 
in the islands
29Strategic Plan Through 2020
Progress is being made at the client level in improving service integration  For example, the vast 
majority of persons diagnosed with TB are screened for HIV  Similarly, increased attention has been 
focused on improving the proportion of STD clinic patients who are screened for HIV and the 
proportion of persons with HIV who are screened for STDs  And programs are urged to offer 
hepatitis C and HIV screening for persons at-risk for both infections 
However, new challenges and opportunities are emerging  In many parts of the country, syphilis 
has increased among men, with most of those increases occurring among MSM who are 
HIV-infected  This increase of syphilis cases may be fueled by increased use of seroadaptive 
behaviors and reliance on treatment as HIV prevention  At the same time, new technologies and 
improvements in intervention science offer the opportunity to improve collaborative work among 
prevention and care programs and the integration of prevention services for at-risk populations 
5.5.1 What NCHHSTP will do
Looking forward, NCHHSTP will
Align surveillance systems, policies, standards and procedures and encourage data use for 
program improvement and data sharing across programs in order to improve efficiency of sur-
veillance and completeness of data, identify the temporal relationship of infection and syndemic 
disease interaction, and identify and address gaps in service provision for at-risk populations
•	  Develop a Center-wide, life course approach to address HIV, viral hepatitis, and STD preven-
tion among MSM that takes into account changing needs from early adolescence through 
late adulthood
•	  Identify and promote opportunities for cross-program training for NCHHSTP staff and public 
health partners
•	  Coordinate health messaging across NCHHSTP programs concerning new prevention tools 
to maximize opportunities for effectively reaching at-risk populations and to minimize 
unintended effects
•	  Identify and leverage opportunities to provide services to prevent co-morbidities, such 
as testing persons taking PrEP for STDs and referral of STD clinic patients with acute STD 
diagnoses to PrEP services
•	  Ensure that project officers/program consultants and grantees maximize opportunities 
for and remove barriers to program collaboration to support service integration at the 
client level
•	  Standardize and improve cooperative agreement planning and management across 
the Center
•	  Develop models and conduct analyses to identify the circumstances in which program 
collaboration and service integration efforts are most likely to be beneficial, the costs of such 
efforts, and factors that contribute to success
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5.5.2 Expected results
These efforts are expected to improve provision of services for individuals at risk of multiple 
infections, thereby reducing co-morbidities and disparities in health  They will also reduce admin-
istrative burden on state and local health department grantees, develop shared capacity that can 
be used across programs and improve the consistency and quality of NCHHSTP’s oversight and 
management, ultimately maximizing the effectiveness and efficiency of NCHHSTP programs 
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5.6  Organizational Excellence: Support excellence in science and 
program; ensure efficient business and scientific administration; 
implement effective communication and policies; enhance skills 
of current staff; and develop the NCHHSTP public health workforce
An effective public health system is critical for building a healthy society and reducing preventable 
disease and death  The cornerstone of such a system is a workforce that is trained and empowered 
to use all available resources to target health improvement efforts, to collaborate with partners 
in health care and other sectors, and to respond when there are urgent threats to the public’s 
health  NCHHSTP has undertaken multiple efforts to build the public health workforce, including 
internships, mentoring programs, career development seminars, and a coaching and leadership 
initiative for its team leads, branch chiefs and division directors 
NCHHSTP has also established business, information, and scientific administrative systems 
to support HIV, viral hepatitis, STD and TB prevention nationwide  Collectively, the Center manages 
multiple cooperative agreements with health departments in every state, Puerto Rico, the Virgin 
Islands, the U S  Affiliated Pacific Islands, and twelve localities  NCHHSTP field staff builds the 
capacity of health departments nationwide to conduct partner services, outbreak investigations 
and other essential public health functions  These field staff have aided in the public health 
response to the anthrax attack of 2001, Hurricane Katrina, Hurricane Sandy, and, most recently, 
the occurrence of Ebola in the United States  NCHHSTP manages cooperative agreements with 
36 state and 21 local education agencies  Further, NCHHSTP also manages cooperative agree-
ments and contracts with multiple universities and non-profit organizations supporting research, 
partnership, training and capacity building  These extramural efforts engage researchers and 
non-profit organizations to provide outside perspectives and solutions to scientific, programmatic 
and policy issues  In addition, NCHHSTP supports the National Prevention Information Network, 
to meet the information sharing needs of NCHHSTP programs and prevention partners 
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5.6.1 What NCHHSTP will do
Achieving NCHHSTP’s HIV, viral hepatitis, STD and TB prevention goals requires that NCHHSTP be 
fit for purpose—that staff are well trained and have efficient and effective systems to support their 
work  To this end, NCHHSTP will continually refine and improve its business and scientific admin-
istration, adapting to the needs of stakeholders and grantees, leveraging new technologies, and 
incorporating new administrative directives  NCHHSTP will maintain effective communication with 
stakeholders and grantees, and conduct business in a transparent manner  In addition, NCHHSTP 
will participate actively in CDC-wide business improvement efforts to ensure that such efforts 
meet the needs of NCHHSTP programs  Finally, NCHHSTP will work to ensure that its staff are well 
trained and can meet current and anticipated program needs  Specifically:
•	  NCHHSTP will work to modernize scientific administration and support continuous improve-
ment of scientific, programmatic, and policy endeavors  For example,
o  NCHHSTP laboratories will play an active role in CDC’s laboratory safety improvement 
initiative
o NCHHSTP will pursue effective methods for improving the quality of the scientific 
process and its information products, implement and evaluate the NCHHSTP science 
quality assurance plan; and identify effective methods for improving research portfolio 
gap analysis and strategies for filling those gaps
o NCHHSTP will continue to support extramural research and program innovation 
and evaluation to help answer questions of public health importance to the nation 
and the world
o NCHHSTP will leverage cooperative research and development agreements, 
Small Business Innovation Research set-asides and other mechanisms to advance 
development of critical scientific products
•	  NCHHSTP will use new technologies and capabilities to improve management and commu-
nication within the Center and with NCHHSTP field staff, grantees, partners, and agencies  
For example, NCHHSTP will
o Improve NCHHSTP administrative systems to be more efficient and effective, with high 
quality and enhanced customer service
o Be at the forefront of CDC’s new Grant Solutions initiative  This program is expected 
to greatly increase the efficiency of grant management at CDC
o Increase the use of commercially available, customizable information technology 
to facilitate collaboration across the Center
o Improve communication with grantees and other prevention partners and program 
stakeholders, through coordinated, transparent communication and outreach 
activities
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•	  NCHHSTP will recruit, develop and support highly trained public health staff who can 
provide leadership and technical expertise in science, policy, programs, and practice 
to improve the health and well-being of the nation and the world  Key tactics include:
o Developing a recruitment and placement strategy to ensure that the best candidates 
are recruited and developed to fill key roles in the field and headquarters
o Improving the collection and monitoring of data on the NCHHSTP workforce to better 
assess and improve the supply, distribution, diversity, and development of the current 
and future workforce
o Fostering a work environment that promotes a healthy work-life balance and a culture 
of recognition for employee contributions and achievements
o Using new technology platforms to facilitate collaboration and training, and improve 
the services offered to health agencies
o Ensuring an effective learning environment that includes sharing critical knowledge 
across the programs, branches and divisions, at headquarters and in the field
o Improving coordination across NCHHSTP, CDC and with other federal agencies to 
ensure a strategic approach to workforce development and succession planning
5.6.2 Expected results
Taken together, these efforts are expected to ensure the quality of NCHHSTP scientific, program-
matic and policy endeavors, as well as the quality of NCHHSTP managerial and administrative 
activities and are expected to attract, maintain, develop, and utilize NCHHSTP’s professional 
workforce to effectively implement prevention activities 
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6. Next Steps
NCHHSTP is committed to broad engagement with staff and stakeholders in its strategic thinking 
and planning  NCHHSTP leaders will incorporate ways to seek new ideas and obtain feedback 
to continue to improve our performance  The Center will rely on staff and internal and external 
partners, including other federal agencies, state and local governments, the research community, 
and nongovernmental partners to work together to achieve its vision, “A Future Free of HIV, Viral 
Hepatitis, STDs, and TB.”
The NCHHSTP Strategic Plan provides an overarching framework that allows for greater respon-
siveness to ever-changing internal and external environments  The Plan provides a more struc-
tured way for NCHHSTP and its partners to think critically and comprehensively about priorities, 
operations and impacts  The divisions in NCHHSTP are developing plans which will operationalize 
this plan  These division plans will provide more detailed and specific goals, strategies, and indica-
tors of progress  Like this plan, the division plans will be made publicly available on CDC’s website 
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7. Implementation, Monitoring, and Evaluation
Achievement of the goals of this plan requires a commitment at every level of the organization  
Each division is working to identify disease-specific objectives and strategies for addressing the 
goals of this plan and achieving division specific programmatic goals  NCHHSTP will take the 
following specific steps to implement, monitor, and evaluate its success 
•	 Provide an electronic copy of the strategic plan to all staff and other key stakeholders
•	 Highlight the plan on both the NCHHSTP internet and intranet sites
•	 Reflect on the NCHHSTP plan when developing or updating NCHHSTP division plans
•	  Discuss accomplishments related to the strategic plan annually at a NCHHSTP 
all-hands meeting
•	 Annually engage NCHHSTP leadership to answer broad questions:
o Are we on track toward achieving our targets? Do they need adjusting?
o Are we focused on our goals and strategies?
o What challenges or opportunities have we encountered? Should these be formulated 
as additional strategies? Do any strategies need elimination or revision?
•	 Report publicly on the strategic plan and major achievements annually
36
Appendix A — Relevant frameworks that guided plan development
1  CDC Mission, Role, and Pledge: http://www cdc gov/about/organization/mission htm  
CDC works 24/7 to protect America from health, safety and security threats, both foreign 
and in the U S  by detecting and responding to new and emerging health threats, tackling 
the biggest health problems causing death and disability for Americans, putting science 
and advanced technology into action to prevent disease, promoting healthy and safe 
behaviors, communities and environment, developing leaders and training the public 
health workforce, including disease detectives, and taking the health pulse of our nation  
CDC pledges to be a diligent steward of the funds entrusted to our agency, provide an 
environment for intellectual and personal growth and integrity, base all public health 
decisions on the highest quality scientific data that is derived openly and objectively, place 
the benefits to society above the benefits to our institution, and treat all persons with 
dignity, honesty, and respect 
2  CDC priorities: http://intranet cdc gov/od/odweb/strategic htm  To achieve its mission, 
CDC is focused on achieving five main public health priorities:
•	 Excellence in surveillance, epidemiology, and laboratory science and services
•	 Support state, tribal, and local health departments
•	 Improve global health
•	 Advance evidence-based health policies
•	 Prevent illness, injury, disability, and premature death
3  CDC Framework for Preventing Infectious Diseases: http://www cdc gov/oid/docs/ID-Frame-
work pdf  CDC’s Infectious Disease Framework provides a roadmap for improving our 
ability to prevent known infectious diseases and to recognize and control rare, highly 
dangerous, and newly emerging threats, through a strengthened, adaptable, and 
multi-purpose U S  public health system  Although its primary purpose is to guide CDC’s 
infectious disease activities, the document is also designed to advance opportunities 
to improve the nation’s health through new ideas, partnerships, technical innovations, 
validated tools, and evidence-based policies 
4  Healthy People 2020: http://www healthypeople gov/  Healthy People provides science-
based, ten-year national objectives for improving the health of all Americans  For more 
than three decades, Healthy People has established benchmarks and monitored progress 
over time in order to encourage collaborations across communities and sectors, empower 
individuals toward making informed health decisions, and measure the impact of preven-
tion activities  Key topic areas under NCHHSTP’s purview include HIV, STD, and Immuniza-
tion and Infectious Diseases (including TB and viral hepatitis) 
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5  National HIV/AIDS Strategy (NHAS): http://www whitehouse gov/administration/eop/onap/
nhas/  President Barack Obama introduced the NHAS in 2010 as a concise plan to identify 
a small number of high payoff action steps that need to be taken to achieve each of the 
President’s goals for HIV prevention  The strategy provides a roadmap for policymakers 
and the general public  It clearly describes the areas that require the most immediate 
change, the specific action steps that must be taken by the Federal Government and 
a variety of stakeholders, and specific targets for measuring our progress toward achieving 
the President’s goals  This National Strategy is being updated; NCHHSTP related indicators 
and targets will be updated as appropriate 
6  HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis (2014–2016): www 
aids gov/hepatitis/  This updated HHS Action Plan is a comprehensive cross-agency action 
plan to combat viral hepatitis  It guides the actions of agencies and offices from across the 
Department of Health and Human Services, as well as with the Departments of Justice, 
Housing and Urban Development, and Veterans Affairs, to prevent new infections and 
improve the diagnosis, care and treatment of individuals living with viral hepatitis in the U S 
7  A Call For Action on the Tuberculosis Elimination Plan of the United States: http://www 
thoracic org/advocacy/stop-tb/Eliminate_TB_USA pdf  The Call for Action was developed 
and issued by Stop TB USA in 2007, to provide an updated plan of action to implement the 
Institute of Medicine’s report Ending Neglect, published in 2001  The plan reviews progress 
on the IOM goals and identifies areas where additional work is needed 
8  National Prevention Strategy (NPS): http://www surgeongeneral gov/initiatives/prevention/
strategy/  Released in 2011, the NPS guides the nation regarding means for improving 
health and well-being of the U S  population  The NPS prioritizes prevention by integrating 
recommendations and actions across multiple settings to improve health and save lives  
The NPS envisions a prevention-oriented society where all sectors recognize the value 
of health for individuals, families, and society and work together to achieve better health 
for Americans  Reproductive and sexual health, to include the prevention of HIV and STDs, 
is one of the seven priorities discussed in the strategy 
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9  Essential public health services are identified by the Public Health Service in Public Health 
in America (1994)  These are:
•	 Monitor health status to identify community health problems 
•	 Diagnose and investigate health problems and health hazards in the community 
•	 Inform, educate, and empower people about health issues 
•	 Mobilize community partnerships to identify and solve health problems 
•	 Develop policies and plans that support individual and community health efforts 
•	 Enforce laws and regulations that protect health and ensure safety 
•	  Link people with needed personal health services and ensure the provision 
of healthcare when otherwise unavailable 
•	 Ensure a competent public health and personal healthcare workforce 
•	  Evaluate effectiveness, accessibility, and quality of personal and population-based 
health services 
•	 Research for new insights and innovative solutions to health problems 
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Appendix B — Indicators
Development of the NCHHSTP Strategic Plan Indicators
To measure progress toward the goals of the NCHHSTP Strategic Plan through 2020, NCHHSTP 
has identified a small set of measurable indicators  These indicators were developed by a 
workgroup of subject matter experts across the Center  The workgroup established criteria for 
indicator selection, developed criteria for selecting targets, and recommended a set of indicators 
representing major efforts 
The indicator set is not comprehensive  The Center and its Divisions currently monitor progress 
on additional indicators that provide a more complete assessment of progress toward key national 
goals  In the future, the NCHHSTP Strategic Plan Indicators set may be amended if annual 
or biennial data become available to measure other important impacts, such as disparities 
in hepatitis B, incidence of latent TB infection, or co-infections  The indicators will be amended and 
updated if additional or better data become available and to reflect significant changes to other 
national plans, such as the National HIV/AIDS Strategy 
Indicator Criteria
1  Indicator reflects one of the most important things for NCHHSTP to measure 
2  A change in the indicator can be attributed, at least in part, to NCHHSTP programs and 
activities 
3  The indicator represents the highest level of outcome which can reasonably be expected 
to be caused by the program  For example, education programs may reasonably 
be expected to result in behavior change 
4  The indicator promotes an honest assessment of program results 
5  The indicator is both easy to understand and concise 
6  One division or office will be responsible for reporting results 
7  Reliable data are currently available in order to establish a baseline  The baseline year may 
not be the same for all indicators, allowing for differences in data systems 
8  Data will continue to be available on an annual or biennial basis until at least 2020 
(the end year of the plan)  If there are anticipated changes to data systems, the changed 
systems will yield data comparable to, or better than, that used for the baseline 
40
Target setting
Targets were set using rates when rates could be calculated and when they were appropriate 
for the given indicator  This aids in comparison across indicators 
Options employed to set targets
•	  Targets are, or will be, aligned with those of major national plans, especially the National 
HIV/AIDS Strategy (NHAS), the HHS Action Plan for Viral Hepatitis, and Healthy People 2020
o Targets for HIV-related indicators will be established to align with the update of the 
NHAS
o Targets for indicators that are related to, but not identical to, other fixed plans were set 
in a similar manner
o Targets for indicators that mirror other national plans may change as those plans are 
updated
•	  The remaining targets were set by NCHHSTP, and were chosen to be realistic and to require 
effort to achieve
o  Most often, targets were set at 5-10 percent improvement from the baseline, similar 
to one of the target-setting methods used for Healthy People 2020
o  Other targets for 2020 were set at the average performance of the top 10 percent 
of jurisdictions at the baseline (2013)
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1.1  Goal 1: Decrease incidence of infection with HIV, 
viral hepatitis, STDs, and TB
Indicator Current Result 2020 Target
1.1 Reduce rate of new diagnoses 
1.1 a HIV 15 0/100,000 (2013) TBD
1.1 b  Acute hepatitis B among adults 
ages 19 and older
1 26 symptomatic cases per 
100,000 population (2013)
0 5 symptomatic 
cases per 100,000
1.1 c Acute hepatitis C 0 7 symptomatic cases per 
100,000 population (2013)
0 25 symptomatic 
cases per 100,000 
population
1.1 d TB 3 0 cases per 100,000 (2013) 1 4 cases per 
100,000 
population
Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with 
the targets in the updated NHAS
HIV 
Numerator: Estimated number of new HIV diagnoses in the United States in the calendar year 
Denominator: Total population in reporting areas
Acute hepatitis B 
Numerator: Number of acute symptomatic cases of hepatitis B among adults ages 19 and older 
reported in the past 12 months
Denominator: Total population ages 19 and older in reporting areas
Acute hepatitis C 
Numerator: Number of acute symptomatic hepatitis C cases reported in the past 12 months
Denominator: Total population in reporting areas
TB 
Numerator: Number of verified, counted TB cases in the United States
Denominator: Population in the United States
Period of reporting: Annual
Data sources: New HIV diagnoses are reported through the National HIV Surveillance System  
New symptomatic cases of hepatitis B and hepatitis C are reported through the National Notifiable 
Disease Surveillance System (NNDSS)  TB cases are reported through the National Tuberculosis 
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Surveillance System (NTSS)  Rates are calculated using several population data sources  Rates 
for HIV are calculated using the U S  Census Bureau’s annual population estimates  Rates for viral 
hepatitis are calculated using the National Center for Health Statistics bridged population data 
file, which is based on U S  Census data  Rates for TB are calculated using the U S  Census’s Annual 
Estimates of the Resident Population for the United States, Regions, States, and Puerto Rico (for 
current results), and the American Community Survey (for calculating targets) 
Alignment with other plans: NHAS, Healthy People 2020 (HIV-1; IID-25, IID-26, IID-29)
Rationale and discussion: The rate of new diagnoses is used here to assess trends in HIV infection, 
acute hepatitis B, acute hepatitis C, and TB  Trends in diagnoses vary per infection, with trends for 
TB declining, while trends for HIV and hepatitis B remain stable, and trends for acute hepatitis C are 
increasing 
The rate of new HIV diagnoses (15 0/100,000) represents 47,352 estimated diagnoses  Overall, the 
rate of new HIV diagnoses in the United States has remained fairly stable in recent years  The num-
ber of new HIV diagnoses attributed to heterosexual contact and injecting drug use has decreased  
These gains have been offset by increases among gay, bisexual and other men have sex with men 
The hepatitis B and hepatitis C incidence rates reflect reported, acute, symptomatic cases  Reported 
cases of acute viral hepatitis represent only those relatively few infected persons who were 
detected, diagnosed, met a stringent surveillance case definition, and eventually reported 
by health departments to CDC  Consequently reported cases underestimate the true incidence 
of infection  However, these reports are useful in analyzing trends in infection and assessing viral 
hepatitis prevention and control programs, policies, and activities  Actual cases of hepatitis B 
are estimated to be approximately 6 6 times the number of reported cases and actual cases 
of hepatitis C are estimated to be approximately 12 times the number of reported cases 
Acute hepatitis B has been declining in incidence since 1990 mainly due to effective vaccination 
strategies  However, for the first time since 1990, the number of reported cases of acute hepatitis 
B increased in 2013, to 3,050 cases  This represented a 5 4% increase from 2012  The vast majority, 
2,968, of these cases occurred among adults ages 19 and older  It may be premature to interpret 
the increase; continued monitoring over more years of data is warranted  The overall incidence 
rate for 2013 was 1 2 cases per 100,000 population (1 26 for adults ages 19 and older)  After adjust-
ing for under-ascertainment and under-reporting, an estimated 19,764 acute hepatitis B cases 
occurred in 2013 
After receiving reports of approximately 800–1,000 cases of acute hepatitis C each year from 
2006–2010, there was a significant increase of 151 5% in reported cases of acute HCV infection 
from 2010 to 2013  The increase is thought to reflect both true increases in incidence and 
improved case ascertainment  New cases of hepatitis C infection are predominately among young 
persons who are white, live in non-urban areas (particularly in Eastern and Midwestern states), 
have a history of injection drug use, and previously used opioid agonists such as oxycodone  The 
overall incidence rate for 2013 was 0 7 cases per 100,000 population, an increase from 2009–2012  
After adjusting for under-ascertainment and under-reporting, an estimated 29,718 new hepatitis C 
infections occurred in 2013 
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The TB incidence rate has steadily decreased in the United States since 1993; the preliminary rates 
for 2014 of 3 0/100,000 is the lowest reported, however, the rate of decline has slowed as cases 
become more difficult to find and treat  The annual number of TB cases represents just a fraction 
of the persons in the U S  who are infected with the TB bacillus  The number of persons who are 
latently infected with TB is estimated periodically using data from the National Health and 
Nutrition Examination Survey (NHANES); the latest available estimate is from 1999-2000 and 
is 11 2 million persons  An estimated 5–10 percent of persons with latent TB infection will go 
on to develop TB disease at some point in their lifetimes  Elimination of TB in the United States 
therefore, requires not only diagnosis and treatment of persons with TB disease, but also diagnosis 
and treatment to cure of persons with latent TB infection 
Target setting method: Targets for HIV will be set to align with updates to NHAS  Targets for acute 
hepatitis B and hepatitis C are aligned with those set for Healthy People 2020  The national TB 
program targets are based on a statistical model that uses data to find trends from 2000 through 
2013  Specifically, the targets are the 90th centile values in 2013 estimated from a quantile regres-
sion on 2000–2013 data, excluding jurisdictions with fewer than 150 cases from 2011–2013 
Indicator Current Result 2020 Target
1.2  Reduce the rate of increase 
of primary & secondary syphilis
10% (2013 v  2012) 5 0%
Numerator: Change in the reported primary and secondary (P&S) syphilis rate per 100,000 total 
U S  population in the current year versus the prior year
Denominator: The rate of P&S syphilis cases per 100,000 total U S  population
Period of reporting: Annual
Data sources: National Notifiable Disease Surveillance System, U S  Census
Alignment with other plans: Healthy People 2020 (STD-7)
Rationale and discussion: This indicator assesses changes in P&S syphilis, the stages at which 
syphilis is most infectious  While rates of P&S syphilis have gone down in some areas, rates are 
increasing among men who have sex with men, particularly in urban areas 
P&S syphilis is measured using nationally notifiable STD surveillance data are collected and 
compiled from reports sent by the STD control programs and health departments in all 50 states, 
the District of Columbia, Guam, Puerto Rico, and the Virgin Islands 
Target setting method: The target is a 50% reduction in the rate of increase over a five year period 
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Indicator Current Result 2019 Target
1.3  Increase the percentage of high school 
students nationwide who abstained from 
sexual intercourse or, if currently sexually 
active, who used a condom during last 
sexual intercourse
86 3% (2013) 90 6%
Numerator: Number of students in grades 9–12 who never had sexual intercourse, ever had 
sexual intercourse but not during the past three months, or had sexual intercourse during the past 
three months (i e , currently sexually active) and used a condom during last sexual intercourse
Denominator: Number of students in grades 9–12
Period of reporting: Biennial
Data source: National Youth Risk Behavior Survey
Alignment with other plans: Measures of condom use and abstinence are included in Healthy 
People 2020 (FP-9 1, FP-9 2, FP-10 3, FP-10 4)
Rationale and discussion: Young people engage in sexual risk behaviors that can result 
in unintended health outcomes  For example, among U S  high school students surveyed in 2013:
•	 46 8 percent had ever had sexual intercourse
•	  34 0 percent had sexual intercourse during the previous 3 months, and, of these 40 9 percent 
did not use a condom the last time they had sexual intercourse
•	 15 0 percent had had sexual intercourse with four or more people during their life
To reduce sexual risk behaviors and related health problems among youth, schools and other 
youth-serving organizations can help young people adopt lifelong attitudes and behaviors that 
support their health and well-being—including behaviors that reduce their risk for HIV, other 
STDs, and unintended pregnancy  This indicator measures self-reported HIV and STD protective 
factors (i e , abstinence or condom use, if sexually active) among teens  It has remained relatively 
stable during the past decade 
Data for this indicator are derived from the National YRBS, a survey of a nationally representative 
sample of students in grades in 9–12 in all regular public and private schools in the 50 states and 
the District of Columbia 
Target setting method: The target is set at a 5 percent improvement above the 2013 baseline  
This target will be challenging, as performance is already high and has changed little during 
the past decade 
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1.2  Goal 2: Decrease morbidity and mortality from HIV, 
viral hepatitis, STDs, and TB
Indicator Current Result 2020 Target
2.1  Reduce deaths from 
viral hepatitis 
2.1.a Hepatitis B 1,873 (2013) 1,754
2.1.b Hepatitis C 19,368 (2013) 16,370
Hepatitis B 
Numerator: Estimated deaths among persons with hepatitis B listed as the cause of death 
or underlying cause of death
Hepatitis C 
Numerator: Estimated deaths among persons with hepatitis C listed as the cause of death 
or underlying cause of death
Period of reporting: Annual
Data sources: National Vital Statistics System
Alignment with other plans: HHS Action Plan for the Prevention, Care and Treatment of Viral Hepatitis
Rationale and discussion: An estimated 800,000 to 1 4 million persons in the United States have 
chronic hepatitis B infection  The number of deaths in the United States due to hepatitis B 
remained relatively stable, ranging from 1,815 in 2007 to 1,873 in 2013  Hepatitis B is preventable 
by appropriate vaccination with the hepatitis B vaccine  CDC also recommends hepatitis B testing 
for target populations to identify and link persons who are infected to appropriate care and 
treatment 
Approximately 3 million Americans are currently infected with the hepatitis C virus, and deaths 
due to hepatitis C have been increasing  From 2007 through 2013, the estimated number of deaths 
in the United States due to hepatitis C increased from 15,106 to 19,368  Without substantial 
public health interventions, this trend is expected to continue  Therapies are available that cure 
hepatitis C in more than 90 percent of persons who complete treatment  However, approximately 
49 percent of people infected with hepatitis C are unaware of their infection and even fewer are 
receiving appropriate care and treatment  This low level of awareness contributes to the increasing 
numbers of hepatitis C-related deaths 
Data for this measure are from CDC’s National Vital Statistics System and reflect those deaths for 
which hepatitis B or hepatitis C is listed as the underlying cause of death or one of the multiple 
causes of death 
Target setting method: Targets for this measure are based on a reduction in forecasted increases 
in hepatitis B and hepatitis C deaths 
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Indicator Current Result 2020 Target
2.2  Increase the percentage of HIV-diagnosed 
persons aged 18 years and older whose 
most recent HIV viral load test in the past 
12 months showed that HIV was suppressed.
42 6% (2011) 44 8%
Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with the 
updated NHAS targets
Numerator: Estimated number of HIV-diagnosed persons aged 18 years and older whose most 
recent HIV viral load test in the past 12 months was less than 200 copies/mL
Denominator: Estimated number of HIV-diagnosed persons aged 18 years and older in the United 
States and Puerto Rico who were diagnosed with HIV prior to the start of the reporting year and 
were alive at the end of the reporting year
Period of reporting: Annual
Data sources: Medical Monitoring Project (MMP), National HIV Surveillance System (NHSS)
Alignment with other plans: NHAS, Healthy People 2020 (HIV-22)
Rationale and discussion: Viral suppression is the primary goal of HIV medical care and treatment  
All persons diagnosed with HIV should receive ongoing HIV medical care and antiretroviral therapy  
Successful antiretroviral treatment suppresses HIV viral load to undetectable or fewer than 200 
copies /mL  Persons living with HIV whose virus is suppressed can have a life expectancy compara-
ble to that of people in the general population  Viral suppression also prevents new HIV infections  
HIV-diagnosed persons who achieve viral suppression have a much lower risk of transmitting HIV 
to others 
MMP data were used to estimate the number of adult persons receiving HIV medical care in the 
United States and Puerto Rico who achieved viral suppression  These data are based on medical 
records of HIV-diagnosed persons who received HIV medical care at least once from January 
to April of the calendar year  HIV viral suppression was assessed using information about the most 
recent HIV viral load test  NHSS data were used to estimate the number of persons who had been 
diagnosed with HIV in the United States or Puerto Rico and were alive at the end of the calendar 
year  NHSS data were adjusted to account for missing data and delays in reporting 
Target setting method: Alignment with other national plans  Data from 2009 were used to estab-
lish the baseline  NHAS established the goal of a 20 percent improvement by 2015 among men 
who have sex with men, Blacks and Hispanics, but did not establish a goal for all persons  The 20 
percent improvement for subgroups was applied to this indicator for all persons with diagnosed 
HIV infection  Targets will be revised to reflect updates to NHAS, when applicable 
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Indicator Current Result 2020 Target
2.3  Increase the proportion of gonorrhea-
infected patients treated with 
a CDC-recommended antibiotic regimen
80 8% (2012) 90%
Numerator: Weighted, population-based estimate of the total number of gonorrhea cases 
documented with appropriate antimicrobial treatment (consistent with CDC recommendations)
Denominator: Total number of gonorrhea cases diagnosed and reported
Period of reporting: Annual
Data source: STD Surveillance Network (SSuN)
Alignment with other plans: N/A
Rationale and Methods: Neisseria gonorrhea has developed resistance to nearly all drugs used 
to treat it  Prompt treatment with an effective antibiotic regimen is necessary to cure infected 
persons and prevent further development and spread of drug resistant infections  This indicator 
assesses the proportion of cases that receive treatment according to CDC’s latest recommendations 
Data for this indicator are derived from the SSuN, a collaborative network comprised of state and 
local STD surveillance units following enhanced STD surveillance protocols  SSuN jurisdictions 
identify a random sample of gonorrhea cases reported for enhanced follow-up which includes 
administration of a standardized patient interview to collect demographic, behavioral, and other 
patient characteristics and collection of demographic and clinical information from the provider, 
including complete ascertainment of treatment 
Target setting method: The target reflects a 10% improvement over baseline 
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Indicator Current Result 2020 Target
2.4  Increase the percentage 
of people who are aware 
of their infection
2.4.a HIV 86 0% (2011) TBD
2.4.b Hepatitis B
33% (2009) 66%
2.4.c Hepatitis C 49% (2002-2011) 66%
Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with 
updates to NHAS
HIV 
Numerator: Estimated number of persons aged 13 years and older who are living with 
diagnosed HIV
Denominator: Estimated number of persons aged 13 years and older who were living with HIV 
infection in the United States in the calendar year  This includes those who had been diagnosed 
with HIV as well as those whose HIV infection was undiagnosed
Hepatitis B 
Numerator: Number of respondents who indicate they were aware they had hepatitis B prior 
to laboratory testing
Denominator: Number of respondents whose laboratory test results are positive for hepatitis B
Hepatitis C 
Numerator: Number of respondents who indicate they were aware they had hepatitis C prior 
to laboratory testing
Denominator: Number of respondents whose laboratory test results are positive for hepatitis C
Period of reporting: HIV: Annual; hepatitis B and hepatitis C: Annual estimates produced 
from pooled data
Data source: HIV: National HIV Surveillance System (NHSS); hepatitis B and hepatitis C: 
the National Health and Nutrition Examination Survey (NHANES)
Alignment with other plans: National Prevention Strategy, NHAS, HHS Action Plan for the 
Prevention, Care and Treatment of Viral Hepatitis (2014 –2016), Healthy People 2020 (HIV-13, IID-27)
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Rationale and discussion: Persons with HIV, hepatitis B, or hepatitis C may live for years without 
being aware of their infection  Knowledge of infection status is a critical first step to medical care, 
treatment, and prevention of transmission to others  Persons who are living with undiagnosed 
infection cannot benefit from effective care and treatments and are at increased risk of disease 
progression and transmission to others  CDC and the U S  Preventive Services Task Force (USPSTF) 
have issued screening recommendations for HIV, hepatitis B and hepatitis C 
HIV surveillance data for adults and adolescents (aged 13 years and older) from the 50 states 
and the District of Columbia were adjusted to account for missing data and delays in reporting  
These data were used to estimate HIV prevalence (the total number of people living with HIV) 
in an extended back-calculation model that considers the estimated annual number of HIV diag-
noses, stage of disease at diagnosis, and the number of deaths among persons with HIV infection  
The number of people living with HIV infection who are unaware of their infection is calculated 
by subtracting the number of people living with diagnosed HIV infection from the overall 
HIV prevalence estimate  This estimate is based on HIV diagnoses, not individual awareness 
of HV status  Some people who were diagnosed with HIV may be unaware of their HIV status 
because they did not receive their test results 
Data for hepatitis B and C come from NHANES, a nationally representative survey of the 
non-institutionalized population of the United States  It is limited in that it excludes incarcerated 
individuals, who are disproportionately affected by hepatitis C  Survey participants are interviewed 
and asked whether they are infected with the hepatitis B or hepatitis C viruses  Subsequent to the 
interview, blood samples are drawn for a series of laboratory tests, including tests for hepatitis B 
and hepatitis C 
Target setting method: Targets for HIV will be set to align with updates to NHAS  Targets for 
hepatitis B and hepatitis C were chosen to align with the HHS Action Plan for the Prevention, 
Care and Treatment of Viral Hepatitis (2014 –2016) 
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Indicator Current Result 2020 Target
2.5  Increase the percentage of sexually 
experienced high school students 
nationwide who have been tested 
for HIV
22 4% (2013) 24 6%
Numerator: Number of students in grades 9–12 who ever had sexual intercourse (i e , sexually 
experienced) and had been tested for HIV, not including tests done when donating blood
Denominator: Number of students in grades 9–12 who ever had sexual intercourse 
(i e , sexually experienced)
Period of reporting: Biennial
Data source: National Youth Risk Behavior Survey
Alignment with other plans: N/A
Rationale and discussion: HIV testing is an integral part of the NHAS and routine testing is one 
of the most important strategies recommended for reducing the spread of HIV and improving 
the health outcomes for those already infected  CDC and the USPSTF recommend HIV screening 
of sexually active adults and adolescents  However, screening of sexually active adolescents has 
been low  HIV-infected adolescents are likely to have recently acquired their infection  CDC aims 
to increase HIV testing among sexually active youth, and has included referral and linkage to HIV 
testing services as a component of its HIV school health programs 
This indicator describes the percentage of sexually experienced high school students who have 
been tested for HIV  HIV testing has not increased or decreased since 2005 (when it was first 
measured), and remains low  There has been no change between 2011 and 2013 
2005 – 20 2 percent
2007 – 22 3 percent
2009 – 22 6 percent
2011 – 22 2 percent
2013 – 22 4 percent
Data for this indicator are derived from the YRBS, a survey of a nationally representative sample 
of students in grades in 9–12 in all regular public and private schools in the 50 states and the 
District of Columbia 
Target setting method: The target is a ten percent improvement above baseline 
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Indicator Current Result 2020 Target
2.6  Increase the percentage of STD clinic 
visits in which patients who are 
diagnosed with an acute STD and are 
not known to be HIV infected are tested 
for HIV 
72% in 2012 79%
Numerator: Number of visits by persons diagnosed with an acute STD at an STD clinic, who are 
not known to be HIV coinfected, in which HIV testing is performed
Denominator: Number of visits by persons diagnosed with an acute STD at an STD clinic, who are 
not known to be HIV coinfected
Period of reporting: Annual
Data source: STD Surveillance Network (SSuN)
Alignment with other plans: N/A
Rationale and discussion: HIV and STDs share common risks and modes of transmission and 
persons diagnosed with STDs are at greatly increased risk of HIV infection  CDC recommends 
that all persons seeking evaluation or care for STDs be screened for HIV  While data are not 
available to assess uptake of this recommendation in all healthcare settings, CDC does monitor 
provision of HIV testing for persons diagnosed with an acute STD in STD clinics operated by health 
departments  In 2011, 19 percent (462,671) of CDC-funded HIV tests in healthcare settings were 
conducted in STD clinics  STD clinics accounted for 25 8 percent of newly identified, confirmed 
HIV diagnoses  Over the prior 4 years, the proportions of persons diagnosed with an STD in an STD 
clinic who were also screened for HIV increased by seven percent 
Data for this indicator are derived from the SSuN, a collaborative network comprised of state and 
local STD surveillance units following enhanced STD surveillance protocols 
Target setting method: The target reflects a 10 percent improvement over baseline 
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Indicator Current Results 2020 Target
2.7  Increase the percentage of young 
sexually active females who were 
screened for Chlamydia trachoma-
tis infection
Women 16–20: 45 1%
Women 21–24: 53 2% 
(2013)
Women 16–20: 49 6%
Women 21–24: 58 5%
Numerator: Women in the eligible population with at least one chlamydia test during the year 
being measured
Denominator: The eligible population (sexually active enrolled women 16–24 years of age 
as of 12/31 of the measurement year)
Period of reporting: Annual
Data source: National Committee for Quality Assurance (NCQA)’s Healthcare Effectiveness Data 
and Information Set (HEDIS)
Alignment with other plans: National Prevention Strategy, Healthy People 2020 (STD-3 and STD-4)
Rationale and discussion: Young women have the highest rates of Chlamydia, and if untreated, 
can suffer serious reproductive health complications such as pelvic inflammatory disease, 
infertility and ectopic pregnancy  CDC and the USPSTF have both recommended annual chlamydia 
screening for sexually active young women 
This indicator is assessed through data reported to the NCQA’s HEDIS and reflects young women 
seen in managed care and preferred provider organizations  The size of the sexually active popula-
tion is defined through administrative claims data  To be included, women may not have any more 
than one gap of >= 45 days in coverage  In HEDIS, separate measures are reported for Medicaid, 
commercial PPO, and commercial HMO plans, for age groups 16–20, 21–24, and 16–24 
Target setting method: The target reflects a 10 percent improvement over baseline 
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1.3  Goal 3: Decrease health disparities across groups affected by HIV, 
viral hepatitis, STDs and TB
Indicator Current Result 2020 Target
3.1  Reduce the rate of new 
diagnoses among 
racial/ethnic popula-
tions with rates above 
the national average
3.1a  Estimated rate of new 
HIV diagnoses
  (national rate: 
15/100,000 in 2013)
Black or African American: 
55 9/100,000
Hispanic or Latino: 18 7/100,000
Multiple race: 16 8/100,000
Black or African American: 
TBD
Hispanic or Latino: TBD
Multiple race: TBD
3.1b Reported rate of TB
   (national rate:   
3.0/100,000 in 2013)
Asian: 18 7/100,000
Native Hawaiian or Other Pacific 
Islander: 11 3/100,000
Hispanic or Latino: 5 0/100,000
Black or African American: 
5 4/100,000
American Indian or 
Alaska Native: 5 4/100,000
Asian: 15 2/100,000
Native Hawaiian or 
Other Pacific Islander: 
5 5/100,000
Hispanic or Latino: 
2 1/100,000
Black or African American: 
2 9/100,000
American Indian or Alaska 
Native: 2 6/100,000
Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with 
updated NHAS targets
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Estimated rates of new HIV diagnoses
Numerator: Estimated number of HIV diagnoses for each of the following groups: Black or African 
American, Hispanic or Latino, and persons for whom multiple race categories were reported
Denominator: Population estimates for Black or African American, Hispanic or Latino, and persons 
for whom multiple race categories were reported
Reported rates of TB 
Numerator: Number of verified counted TB cases in the United States among Asians, Blacks 
or African Americans, Hispanics or Latinos, Native Hawaiians or Other Pacific Islanders, and 
American Indians or Alaska Natives
Denominator: Population estimates for Asian, Black or African American, Hispanic or Latino, 
Native Hawaiian or Other Pacific Islander, and American Indian or Alaska Native
Period of reporting: Annual
Data sources: New HIV diagnoses are reported through the National HIV Surveillance System  
TB cases are reported through the National Tuberculosis Surveillance System (NTSS)  HIV rates 
are calculated using the U S  Census Bureau’s annual population estimates  TB rates are calculated 
using the U S  Census Bureau’s National Population Estimates (for current results) and the American 
Community Survey (for calculating targets) 
Alignment with other plans: NHAS
Rationale and discussion: The infections addressed by NCHHSTP are not equally spread across 
the population; racial and ethnic minority populations are often disproportionately affected  
Contributing factors include social and environmental determinants, including poor access 
to health care, stigma, discrimination, homophobia, low educational attainment, immigration 
status, and poverty  This indicator will be used to assess progress in reducing racial/ethnic 
disparities for HIV and TB 
Target setting method: Targets have been established for all racial/ethnic subpopulations with 
rates above the national average  HIV targets have been set using numbers instead of rates, 
in order to align with the NHAS  The TB targets are based on a statistical model that uses data 
to find trends from 2000 through 2013  Specifically, the targets are the 90th centile values in 2013 
estimated from a quantile regression on 2000–2013 data, excluding jurisdictions reported less 
than an average of 50 total cases per year from 2011–2013  Jurisdictions with respective racial/
ethnic population below 500,000 persons, and which reported fewer than an average of 1 case per 
year in the respective racial/ethnic population from 2011–2013 are also excluded 
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Indicator Current Results 2020 Target
3.2  Reduce new HIV infections among 
high-risk populations:
 - people who inject drugs





Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with 
updates to NHAS
Persons who inject drugs (PWID) 
Numerator: Number of persons, aged 13 and older, diagnosed with HIV who reported a history 
of or current injection drug use
Denominator: Estimated number of persons in the United States, aged 13 and older, who report 
a history of, or current injection drug use
Men who have sex with men (MSM) 
Numerator: Number of men, aged 13 and older diagnosed with HIV who have had sexual contact 
with other men
Denominator: Estimated number of men in the United States, aged 13 and older, who have had 
sex with other men
Period of reporting: Annual
Data sources: National Notifiable Diseases Surveillance System (NNDSS), U S  Census
Alignment with other plans: Healthy People 2020 (HIV-6, HIV-7)
Rationale and discussion: MSM and PWID are at increased risk for HIV  CDC has estimated the size 
of the U S  population that engages in male to male sexual contact and has used these data 
to estimate rates of HIV among MSM  Similar analyses have been completed to estimate the 
number of persons who have ever injected drugs and this data has been used to calculate rates 
of HIV infection among this population 
New HIV diagnoses are used for this indicator to assess trends in infection over time  In 2013, there 
were an estimated 31,023 HIV diagnoses among men who have sex with men  This translates 
to a rate of 349 30/100,000 persons 13 years of age and older  There were 3,239 diagnoses among 
people who inject drugs, which translates to a rate of 47 29 per 100,000 persons aged 13 and 
older 
Target setting method: Alignment with national plans, i e , Healthy People 2020
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Indicator Current Result 2020 Target
3.3  Reduce the number of TB cases 
in foreign-born persons per 
100,000 per year
15 6 per 100,000 (2013) 11 1 cases per 100,000
Numerator: Number of verified counted TB cases in foreign-born persons
Denominator: Population of foreign-born persons in the United States in the year of interest
Period of reporting: Annual
Data sources: The National Tuberculosis Surveillance System (NTSS), U S  Census’s 
Current Population Survey (for current results) and the American Community Survey 
(for calculating targets)
Alignment with other plans: N/A
Rationale and discussion: Persons born outside of the United States account for more than 
50 percent of the new TB cases in the United States  Reducing TB incidence in this population 
is important to both reducing this disparity in health and to reducing TB in the United States 
as a whole 
Rates are derived from TB cases reported through the NTSS from the 50 states and the 
District of Columbia 
Target setting method: Targets are based on a statistical model that uses data to find trends from 
2000 through 2013  Specifically, the targets are the 90th centile values in 2013 estimated from 
a quantile regression on 2000–2013 data, excluding jurisdictions with a foreign-born population 
below 500,000 persons or fewer than 150 total cases from 2011–2013 
Indicator Current Result 2020 Target
3.4   Increase the percentage 
of HIV-diagnosed men who have 
sex with men (MSM), blacks/African 
Americans, and Hispanics/Latinos 
aged 18 years and older whose 
most recent HIV viral load test 




or African American: 34 9%
Hispanic or Latino: 37 2%
(2010)
MSM: 48 8%
Black or African 
American: 39 2%
Hispanics 
or Latinos: 43 9%
Note:  As necessary, this indicator will be revised to reflect updates to NHAS in 2015  Targets will be aligned with the 
targets in the updated NHAS
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Numerator: Estimated number of HIV-diagnosed adult MSM, Blacks or African Americans, 
or Hispanics or Latinos in HIV medical care whose most recent viral load test in the past 12 months 
showed that HIV was suppressed
Denominator: Estimated number of HIV-diagnosed adult MSM, Blacks or African Americans, 
or Hispanics or Latinos aged 18 years and older in the United States and Puerto Rico who were 
diagnosed with HIV prior to the start of the reporting year and were alive at the end of the 
reporting year
Period of reporting: Annual
Data sources: Medical Monitoring Project (MMP), National HIV Surveillance System (NHSS)
Alignment with other plans: NHAS
Rationale and discussion: Viral suppression is the primary goal of HIV medical care and treatment 
for all persons living with HIV  Everyone who is diagnosed with HIV should receive ongoing HIV 
medical care and antiretroviral therapy  Successful antiretroviral treatment suppresses HIV viral 
load to undetectable or fewer than 200 copies /mL  Persons living with HIV whose virus 
is suppressed can have a life expectancy comparable to that of people in the general population  
Viral suppression also prevents new HIV infections  HIV-diagnosed persons who achieve viral 
suppression have a much lower risk of transmitting HIV to others 
This indicator assesses viral suppression among three populations—MSM, Blacks or African 
Americans, and Hispanics or Latinos—that are disproportionately affected by HIV  By monitoring 
outcomes in these disproportionately affected populations, NCHHSTP can assess progress toward 
reducing health disparities 
MMP data were used to estimate the number of adult MSM, Blacks or African Americans, and 
Hispanics or Latinos receiving HIV medical care in the United States and Puerto Rico who achieved 
viral suppression  These data are based on medical records of HIV-diagnosed persons who 
received HIV medical care at least once from January to April of the calendar year  HIV viral 
suppression was assessed using information about the most recent HIV viral load test  NHSS data 
were used to estimate the number of MSM, Blacks or African Americans, and Hispanics or Latinos 
who had been diagnosed with HIV in the United States or Puerto Rico and were alive at the end 
of the calendar year  NHSS data were adjusted to account for missing data and delays in reporting 
Target setting method: Alignment with other national plans, i e , NHAS  Data from 2009 were 
used to establish the baseline, and 2020 targets reflect 20 percent increase over the baseline, 
as called for in NHAS  Targets will be revised to reflect updates to NHAS, when applicable 
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Indicator Current Result 2020 Target
3.5  Decrease the percentage of sexual 
minority male high school students 
in major urban centers who have 
engaged in HIV/STD risk behaviors 
34 1% (2013) 30 7% (2019)
Numerator: Number of male students in grades 9–12 from 15 large urban school districts 
who had sexual contact with only males or with both males and females and who had sexual 
intercourse during the past three months with three or more persons, or had sexual intercourse 
during the past three months and did not use a condom during last sexual intercourse, or ever 
injected any illegal drug
Denominator: Number of male students in grades 9–12 from 15 large urban school districts who 
had sexual contact with only males or with both males and females
Period of reporting: Biennial
Data source: Local Youth Risk Behavior Surveys conducted in 15 large urban school districts
Alignment with other plans: N/A
Rationale and discussion: Nationally, young men who have sex with men have the highest rates 
of HIV incidence and are the only group among whom infections rates have been rising  This 
indicator measures risk behaviors among males who have had sexual contact with males in grades 
9–12 in 15 large urban school districts  These school districts asked a question about sex of sexual 
contacts in their 2013 Youth Risk Behavior Survey  Additional large urban school districts will ask 
this question starting in 2015 
Target setting method: The target is a ten percent reduction from baseline 
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